Biology of anemia, differential diagnosis, and treatment options in human immunodeficiency virus infection

J Infect Dis. 2002 May 15:185 Suppl 2:S105-9. doi: 10.1086/340202.

Abstract

Anemia is the most common hematologic manifestation of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome. The causes of HIV-related anemia are multifactorial and include direct and indirect effects of HIV infection. HIV-related anemia generally is due to reduced red blood cell (RBC) production, secondary to a variety of causes, but it may also involve nutritional deficiencies, increased RBC destruction, or a combination of these problems. Evaluation of hemoglobin level, reticulocyte count, bilirubin, and mean corpuscular volume value and review of the peripheral blood smear are necessary for diagnosis. Treatment of HIV-related anemia should address the correctable underlying causes of this disorder, such as modifications of offending medications, nutritional deficiencies, and parvovirus infection. Patients with HIV infection have a blunted erythropoietin response to anemia. Therapeutic modalities for anemia that is not amenable to correction include blood transfusion and recombinant human erythropoietin (epoetin alfa).

Publication types

  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Anemia* / diagnosis
  • Anemia* / etiology
  • Anemia* / therapy
  • Anti-HIV Agents / therapeutic use
  • Diagnosis, Differential
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Humans

Substances

  • Anti-HIV Agents